Company intelligence / Profile preview

Hupan Pharmaceutical

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Hupan Pharmaceutical is a comprehensive pharmaceutical distributor providing commercial-scale logistics and supply chain solutions for hospitals in Hubei, China. While it does not develop its own clinical candidates, it distributes approved oncology, immunotherapy, and critical care drugs from major manufacturers, partnering with leading pharma firms for market access and large-scale distribution.

Therapeutic areas: OncologyInfectious DiseasesDermatologyOther
Modalities: Small moleculeBiologicPeptidesParenteral solutions
Industry: Non-Academic Healthcare

Partnerships

Sinopharm Group Hubei Co., Ltd.Sichuan Huiyu Pharmaceutical Co., Ltd.Hubei Kelun Pharmaceutical Trading Co., Ltd.Multiple major hospitals in Wuhan

Beyond the preview

Go deeper on Hupan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hupan Pharmaceutical.

Explore the full profile